ArticleCirculation reports2019

Comparison of Canagliflozin, Dapagliflozin and Empagliflozin Added to Heart Failure Treatment in Decompensated Heart Failure Patients With Type 2 Diabetes Mellitus.

Masaki Nakagaito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.